CYP2C9 Catalyst Model | Permuted Hypothesis 1 | Permuted Hypothesis 2 | ||||
---|---|---|---|---|---|---|
Pharmacophore Features | Hypothesis–Null Energy Cost | Pharmacophore Fit | Pharmacophore Features | Hypothesis–Null Energy Cost | Pharmacophore Fit | |
r | r | |||||
16-a | 1 HBA, 1 HBD, 2 H | 35.9–33.9 | 0.81 | 1 HBA, 1 HBD, 2 H | 42.8–33.9 | 0.69 |
26-b | 1 HBA, 1 HBD, 2 H | 130.3–130.5 | 0.58 | 1 HBA, 3H | 130.4–130.5 | 0.66 |
36-c | 2 HBA | 55.4–47.9 | 0.29 | 2 HBA | 55–47.9 | 0.20 |